| Molecular Imaging and Radionuclide Therapy | |
| The Prognostic Value of 18 F-FDG PET/CT Metabolic Parameters in Predicting Treatment Response Before EGFR TKI Treatment in Patients with Advanced Lung Adenocarcinoma | |
| article | |
| Nurşin Agüloğlu1  Murat Akyol2  Halil Kömek3  Nuran Katgı4  | |
| [1] University of Health Sciences Turkey, Dr. Suat Seren Chest Diseases and Surgery Hospital, Clinic of Nuclear Medicine;İzmir Bakırçay University Faculty of Medicine, Department of Medical Oncology;Gazi Yaşargil Training and Research Hospital, Clinic of Nuclear Medicine;University of Health Sciences Turkey, Dr. Suat Seren Chest Diseases and Surgery Hospital, Clinic of Chest Diseases | |
| 关键词: 18F-FDG PET/CT; lung cancer; adenocarcinoma; EGFR; progression-free survival; overall survival; | |
| DOI : 10.4274/mirt.galenos.2022.24650 | |
| 来源: Turkiye Nukleer Tip Dernegi | |
PDF
|
|
【 摘 要 】
Objectives: This study makes a retrospective examination of exploring the prognostic value of 18 fluorine-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) related metabolic-volumetric variables, nutritional status, and immune and inflammatory markers on progression-free survival (PFS) and overall survival (OS) in advanced adenocarcinoma patients with positive epidermal growth factor receptor (EGFR) mutations undergoing EGFR tyrosine kinase inhibitor (TKI) therapy. Methods: A retrospective examination was made of patients diagnosed with lung adenocarcinoma who underwent 18 F-FDG PET/CT imaging for staging maximum four weeks before starting treatment, between January 2015 and July 2020. Included in the study were 68 patients identified histopathologically to have locally advanced/metastatic EGFR mutation-positive adenocarcinoma, and who underwent EGFR TKI therapy. The laboratory data of the patients, obtained 15 days before imaging performed for PET/CT staging, were evaluated. Results: Metabolic tumor volume, modified Glasgow prognostic score and locally advanced disease were identified as independent prognostic parameters for PFS (p=0.004, p=0.029, p=0.016, respectively). A univariate Cox regression analysis revealed albumin/alkaline phosphatase and tumor size to be significant parameters for prognosis (p=0.033, p=0.043, respectively). A multivariate Cox regression analysis revealed that none of the parameters were predictive or OS. Conclusion: The parameters of 18 F-FDG PET/CT, especially the volumetric parameters, were found to be strong prognostic factors with statistical significance for predicting PFS. We believe that these parameters are important prognostic markers that should be evaluated together in the management and follow-up of patients with EGFR mutation-positive adenocarcinoma.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202301300015106ZK.pdf | 175KB |
PDF